UniProt ID | SCMC1_HUMAN | |
---|---|---|
UniProt AC | Q6NUK1 | |
Protein Name | Calcium-binding mitochondrial carrier protein SCaMC-1 | |
Gene Name | SLC25A24 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 477 | |
Subcellular Localization |
Mitochondrion inner membrane Multi-pass membrane protein . |
|
Protein Description | Calcium-dependent mitochondrial solute carrier. Mediates the reversible, electroneutral exchange of Mg-ATP or Mg-ADP against phosphate ions, catalyzing the net uptake or efflux of adenine nucleotides across the mitochondrial inner membrane. Nucleotide transport is inactive when cytosolic calcium levels are low, and is activated by an increase in cytosolic calcium levels. May play a role in protecting cells against oxidative stress-induced cell death, probably by promoting the formation of calcium-phosphate precipitates in the mitochondrial matrix, and thereby buffering calcium levels in the mitochondrial matrix.. | |
Protein Sequence | MLRWLRDFVLPTAACQDAEQPTRYETLFQALDRNGDGVVDIGELQEGLRNLGIPLGQDAEEKIFTTGDVNKDGKLDFEEFMKYLKDHEKKMKLAFKSLDKNNDGKIEASEIVQSLQTLGLTISEQQAELILQSIDVDGTMTVDWNEWRDYFLFNPVTDIEEIIRFWKHSTGIDIGDSLTIPDEFTEDEKKSGQWWRQLLAGGIAGAVSRTSTAPLDRLKIMMQVHGSKSDKMNIFGGFRQMVKEGGIRSLWRGNGTNVIKIAPETAVKFWAYEQYKKLLTEEGQKIGTFERFISGSMAGATAQTFIYPMEVMKTRLAVGKTGQYSGIYDCAKKILKHEGLGAFYKGYVPNLLGIIPYAGIDLAVYELLKSYWLDNFAKDSVNPGVMVLLGCGALSSTCGQLASYPLALVRTRMQAQAMLEGSPQLNMVGLFRRIISKEGIPGLYRGITPNFMKVLPAVGISYVVYENMKQTLGVTQK | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
37 | Ubiquitination | ALDRNGDGVVDIGEL HHHHCCCCCEEHHHH | 23.81 | 24816145 | |
46 (in isoform 2) | Phosphorylation | - | 73.20 | 24275569 | |
62 | Ubiquitination | LGQDAEEKIFTTGDV CCCCCCHHCEECCCC | 34.33 | 22817900 | |
62 (in isoform 1) | Ubiquitination | - | 34.33 | 21890473 | |
62 | 2-Hydroxyisobutyrylation | LGQDAEEKIFTTGDV CCCCCCHHCEECCCC | 34.33 | - | |
71 | Ubiquitination | FTTGDVNKDGKLDFE EECCCCCCCCCCCHH | 68.64 | 29967540 | |
74 | Ubiquitination | GDVNKDGKLDFEEFM CCCCCCCCCCHHHHH | 55.83 | 29967540 | |
81 | Sulfoxidation | KLDFEEFMKYLKDHE CCCHHHHHHHHHHHH | 2.93 | 21406390 | |
185 | Phosphorylation | LTIPDEFTEDEKKSG EECCCCCCCCHHHCC | 40.24 | - | |
208 | Phosphorylation | GGIAGAVSRTSTAPL HHHHHCCCCCCCCCH | 29.34 | 20068231 | |
224 | Ubiquitination | RLKIMMQVHGSKSDK HHHHHHHHHCCCCCC | 2.76 | 24816145 | |
228 | Acetylation | MMQVHGSKSDKMNIF HHHHHCCCCCCCCCC | 68.23 | 26210075 | |
228 | Malonylation | MMQVHGSKSDKMNIF HHHHHCCCCCCCCCC | 68.23 | 26320211 | |
229 | Phosphorylation | MQVHGSKSDKMNIFG HHHHCCCCCCCCCCH | 44.13 | 20068231 | |
231 | Malonylation | VHGSKSDKMNIFGGF HHCCCCCCCCCCHHH | 40.72 | 26320211 | |
232 | Sulfoxidation | HGSKSDKMNIFGGFR HCCCCCCCCCCHHHH | 5.81 | 28465586 | |
243 | Succinylation | GGFRQMVKEGGIRSL HHHHHHHHHCCCCCE | 45.35 | 27452117 | |
243 | Acetylation | GGFRQMVKEGGIRSL HHHHHHHHHCCCCCE | 45.35 | 23236377 | |
243 | Ubiquitination | GGFRQMVKEGGIRSL HHHHHHHHHCCCCCE | 45.35 | 24816145 | |
249 | Phosphorylation | VKEGGIRSLWRGNGT HHHCCCCCEEECCCC | 30.29 | 24719451 | |
266 | Ubiquitination | IKIAPETAVKFWAYE EEECHHHHHHHHHHH | 10.80 | 32015554 | |
276 | Acetylation | FWAYEQYKKLLTEEG HHHHHHHHHHHCHHH | 36.32 | 27452117 | |
285 | 2-Hydroxyisobutyrylation | LLTEEGQKIGTFERF HHCHHHCCEECHHHH | 54.69 | - | |
285 | Ubiquitination | LLTEEGQKIGTFERF HHCHHHCCEECHHHH | 54.69 | 32015554 | |
288 | Phosphorylation | EEGQKIGTFERFISG HHHCCEECHHHHHCC | 26.29 | 22210691 | |
294 | Phosphorylation | GTFERFISGSMAGAT ECHHHHHCCCCCCCC | 23.31 | 22210691 | |
317 | Ubiquitination | EVMKTRLAVGKTGQY HHHHHEEECCCCCCC | 12.53 | 29967540 | |
317 | Acetylation | EVMKTRLAVGKTGQY HHHHHEEECCCCCCC | 12.53 | 19608861 | |
320 | Succinylation | KTRLAVGKTGQYSGI HHEEECCCCCCCCCH | 42.77 | 27452117 | |
320 | Acetylation | KTRLAVGKTGQYSGI HHEEECCCCCCCCCH | 42.77 | 25825284 | |
320 | Succinylation | KTRLAVGKTGQYSGI HHEEECCCCCCCCCH | 42.77 | - | |
320 | 2-Hydroxyisobutyrylation | KTRLAVGKTGQYSGI HHEEECCCCCCCCCH | 42.77 | - | |
320 | Malonylation | KTRLAVGKTGQYSGI HHEEECCCCCCCCCH | 42.77 | 26320211 | |
324 | Phosphorylation | AVGKTGQYSGIYDCA ECCCCCCCCCHHHHH | 15.37 | 22817900 | |
328 | Phosphorylation | TGQYSGIYDCAKKIL CCCCCCHHHHHHHHH | 14.43 | 25839225 | |
332 | Acetylation | SGIYDCAKKILKHEG CCHHHHHHHHHHHCC | 46.83 | 26051181 | |
332 | Succinylation | SGIYDCAKKILKHEG CCHHHHHHHHHHHCC | 46.83 | 23954790 | |
332 | Malonylation | SGIYDCAKKILKHEG CCHHHHHHHHHHHCC | 46.83 | 26320211 | |
336 | 2-Hydroxyisobutyrylation | DCAKKILKHEGLGAF HHHHHHHHHCCCCHH | 42.98 | - | |
336 | Malonylation | DCAKKILKHEGLGAF HHHHHHHHHCCCCHH | 42.98 | 26320211 | |
336 | Acetylation | DCAKKILKHEGLGAF HHHHHHHHHCCCCHH | 42.98 | 19608861 | |
336 | Ubiquitination | DCAKKILKHEGLGAF HHHHHHHHHCCCCHH | 42.98 | 29967540 | |
336 | Succinylation | DCAKKILKHEGLGAF HHHHHHHHHCCCCHH | 42.98 | 27452117 | |
357 | Phosphorylation | NLLGIIPYAGIDLAV CHHCCCCCCCHHHHH | 13.67 | - | |
370 | Phosphorylation | AVYELLKSYWLDNFA HHHHHHHHHHHHHCH | 22.85 | - | |
371 | Phosphorylation | VYELLKSYWLDNFAK HHHHHHHHHHHHCHH | 14.38 | 21712546 | |
380 | Phosphorylation | LDNFAKDSVNPGVMV HHHCHHCCCCCCCEE | 24.08 | 20068231 | |
395 | Phosphorylation | LLGCGALSSTCGQLA EECCCHHHCHHHHHH | 24.06 | 20068231 | |
396 | Phosphorylation | LGCGALSSTCGQLAS ECCCHHHCHHHHHHC | 28.68 | 20068231 | |
397 | Phosphorylation | GCGALSSTCGQLASY CCCHHHCHHHHHHCH | 19.78 | 20068231 | |
403 | Phosphorylation | STCGQLASYPLALVR CHHHHHHCHHHHHHH | 35.56 | 20068231 | |
404 | Phosphorylation | TCGQLASYPLALVRT HHHHHHCHHHHHHHH | 9.17 | 20068231 | |
418 | Acetylation | TRMQAQAMLEGSPQL HHHHHHHHHCCCCCC | 2.02 | 19608861 | |
422 | Phosphorylation | AQAMLEGSPQLNMVG HHHHHCCCCCCCHHH | 10.49 | - | |
437 | Malonylation | LFRRIISKEGIPGLY HHHHHHHHCCCCCHH | 49.94 | 26320211 | |
437 | Succinylation | LFRRIISKEGIPGLY HHHHHHHHCCCCCHH | 49.94 | - | |
437 | Succinylation | LFRRIISKEGIPGLY HHHHHHHHCCCCCHH | 49.94 | 27452117 | |
437 | Acetylation | LFRRIISKEGIPGLY HHHHHHHHCCCCCHH | 49.94 | 19608861 | |
448 | Phosphorylation | PGLYRGITPNFMKVL CCHHCCCCCCHHHHH | 18.27 | - | |
461 | Phosphorylation | VLPAVGISYVVYENM HHHHCCCEEEEEECH | 13.12 | - | |
462 | Phosphorylation | LPAVGISYVVYENMK HHHCCCEEEEEECHH | 7.63 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of SCMC1_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of SCMC1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SCMC1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
Oops, there are no PPI records of SCMC1_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-336 AND LYS-437, AND MASSSPECTROMETRY. |